Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30262659

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2018 Nov 22
First author
Tun HW

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Tun HW
      type
      Author
    2. name
      Johnston PB
      type
      Author
    3. name
      DeAngelis LM
      type
      Author
    4. name
      Atherton PJ
      type
      Author
    5. name
      Pederson LD
      type
      Author
    6. name
      Koenig PA
      type
      Author
    7. name
      Reeder CB
      type
      Author
    8. name
      Omuro AMP
      type
      Author
    9. name
      Schiff D
      type
      Author
    10. name
      O'Neill B
      type
      Author
    11. name
      Pulido J
      type
      Author
    12. name
      Jaeckle KA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Tun HW
      type
      Author
    2. name
      Johnston PB
      type
      Author
    3. name
      DeAngelis LM
      type
      Author
    4. name
      Atherton PJ
      type
      Author
    5. name
      Pederson LD
      type
      Author
    6. name
      Koenig PA
      type
      Author
    7. name
      Reeder CB
      type
      Author
    8. name
      Omuro AMP
      type
      Author
    9. name
      Schiff D
      type
      Author
    10. name
      O'Neill B
      type
      Author
    11. name
      Pulido J
      type
      Author
    12. name
      Jaeckle KA
      type
      Author
    bibliography ids
    1. nci-bib-4ec5a5075a1714bdc41ecbe6
    book metadata
    content sha256
    1f14ea9021589ea487900c607e3f0cf5dab385ce87b7a4b0293259f38dc301df
    document type
    citation
    dois
    1. 10.1182/blood-2018-02-835496
    electronic publication date
    display
    2018 Sep 27
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30262659
    immutable id
    pubmed:30262659@1f14ea9021589ea487900c607e3f0cf5dab385ce87b7a4b0293259f38dc301df
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    21
    name
    Blood
    nlm unique id
    7603509
    pages
    2240-2248
    volume
    132
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30262659
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      e2ad45b83e3941c6e24708591b96327709bf3a7cb3fe6e72749ea38dcbb21119
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2018 Nov 22
      precision
      day
      year
      2018
      publication types
      1. Clinical Trial, Phase I
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30262659/
      title
      Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma.

      Preserved source evidence · Not medical advice